4.5 Article

Thioredoxin and dihydrolipoic acid are required for 3-mercaptopyruvate sulfurtransferase to produce hydrogen sulfide

Journal

BIOCHEMICAL JOURNAL
Volume 439, Issue -, Pages 479-485

Publisher

PORTLAND PRESS LTD
DOI: 10.1042/BJ20110841

Keywords

dihydrolipoic acid (DHLA); dithiol; hydrogen sulfide (H(2)S); 3-mercaptopyruvate sulfurtransferase (3MST); thioredoxin

Funding

  1. KAKENHI [23659089, 23790316, 23700434, 22590258]
  2. Ministry of Health Labour and Welfare
  3. National Institute of Neuroscience
  4. Grants-in-Aid for Scientific Research [22590258, 23659089, 23790316, 23700434] Funding Source: KAKEN

Ask authors/readers for more resources

H(2)S (hydrogen sulfide) has recently been recognized as a signalling molecule as well as a cytoprotectant. We recently demonstrated that 3MST (3-mercaptopyruvate sulfurtransferase) produces H(2)S from 3MP (3-mercaptopyruvate). Although a reducing substance is required for an intermediate persulfide at the active site of 3MST to release H(2)S, the substance has not been identified. In the present study we show that Trx (thioredoxin) and DHLA (dihydrolipoic acid) associate with 3MST to release H(2)S. Other reducing substances, such as NADPH, NADH, GSH, cysteine and CoA, did not have any effect on the reaction. We also show that 3MST produces H(2)S from thiosulfate. The present study provides a new insight into a mechanism for the production of H(2)S by 3MST.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available